171 related articles for article (PubMed ID: 14551273)
1. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors.
Lu DS; Raman SS; Limanond P; Aziz D; Economou J; Busuttil R; Sayre J
J Vasc Interv Radiol; 2003 Oct; 14(10):1267-74. PubMed ID: 14551273
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
Vietti Violi N; Duran R; Guiu B; Cercueil JP; Aubé C; Digklia A; Pache I; Deltenre P; Knebel JF; Denys A
Lancet Gastroenterol Hepatol; 2018 May; 3(5):317-325. PubMed ID: 29503247
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?
Goldberg SN; Hahn PF; Tanabe KK; Mueller PR; Schima W; Athanasoulis CA; Compton CC; Solbiati L; Gazelle GS
J Vasc Interv Radiol; 1998; 9(1 Pt 1):101-11. PubMed ID: 9468403
[TBL] [Abstract][Full Text] [Related]
4. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
;
J Hepatol; 2018 Jul; 69(1):182-236. PubMed ID: 29628281
[No Abstract] [Full Text] [Related]
5. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.
Kim YS; Lim HK; Rhim H; Lee MW; Choi D; Lee WJ; Paik SW; Koh KC; Lee JH; Choi MS; Gwak GY; Yoo BC
J Hepatol; 2013 Jan; 58(1):89-97. PubMed ID: 23023009
[TBL] [Abstract][Full Text] [Related]
6. Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model.
Yu NC; Raman SS; Kim YJ; Lassman C; Chang X; Lu DS
J Vasc Interv Radiol; 2008 Jul; 19(7):1087-92. PubMed ID: 18589324
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
[TBL] [Abstract][Full Text] [Related]
8. Surgical and Interventional Management of Liver Metastasis.
Itenberg ER; Lozano AM
Clin Colon Rectal Surg; 2024 Mar; 37(2):80-84. PubMed ID: 38322597
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation.
Ye F; Xie L; Liang L; Zhou Z; He S; Li R; Lin L; Zhu K
J Interv Med; 2023 Nov; 6(4):160-169. PubMed ID: 38312128
[TBL] [Abstract][Full Text] [Related]
10. Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes.
Cha DI; Lee MW; Hyun D; Ahn SH; Jeong WK; Rhim H
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958370
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous Microwave Ablation of Hepatocellular Carcinoma with "Double Fusion" Technique: Technical Note and Single-Center Preliminary Experience.
Biondetti P; Ascenti V; Shehab A; Ierardi AM; Carriero S; Lanza C; Angileri SA; Guzzardi G; Carrafiello G
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510092
[TBL] [Abstract][Full Text] [Related]
12. Interventional radiological therapies in colorectal hepatic metastases.
Vulasala SSR; Sutphin PD; Kethu S; Onteddu NK; Kalva SP
Front Oncol; 2023; 13():963966. PubMed ID: 37324012
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging for treatment response evaluation and prognostication of hepatocellular carcinoma after thermal ablation.
Zhang Y; Wei H; Song B
Insights Imaging; 2023 May; 14(1):87. PubMed ID: 37188987
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma.
Liu M; Li XJ; Zhang XE; Kuang M; Xie XY; Huang GL
Diagn Interv Radiol; 2023 Mar; 29(2):342-349. PubMed ID: 36987999
[TBL] [Abstract][Full Text] [Related]
15. Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation.
Odet J; Pellegrinelli J; Varbedian O; Truntzer C; Midulla M; Ghiringhelli F; Orry D
J Imaging; 2023 Mar; 9(3):. PubMed ID: 36976117
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Radiofrequency Ablation Combined with Transarterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Non-hepatocellular Carcinoma Malignant Liver Tumors.
Yoshihara T; Hasegawa T; Sato Y; Yamaura H; Murata S; Chatani S; Tsukii R; Nagasawa K; Tsushima Y; Inaba Y
Interv Radiol (Higashimatsuyama); 2023 Mar; 8(1):7-13. PubMed ID: 36936255
[TBL] [Abstract][Full Text] [Related]
17. Risk Group Stratification for Recurrence-Free Survival and Early Tumor Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma.
Cha DI; Ahn SH; Lee MW; Jeong WK; Song KD; Kang TW; Rhim H
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765645
[TBL] [Abstract][Full Text] [Related]
18. Nanosecond pulsed electric field ablation-induced modulation of sphingolipid metabolism is associated with Ly6c2
Liu J; Fang C; Jin X; Tian G; Sun Z; Hong L; Pan J; Chen X; Zhao J; Cao H; Jiang T
Mol Oncol; 2023 Jun; 17(6):1093-1111. PubMed ID: 36587393
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Abscess Development Following Percutaneous Microwave Ablation Therapy of Hepatic Tumors.
Kwak DH; Yu Q; Malavia M; Sellers E; Said A; Patel M; Kumari D; Ahmed O
Cardiovasc Intervent Radiol; 2023 Jun; 46(6):726-736. PubMed ID: 36478028
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous radiofrequency ablation of hepatocellular carcinoma in a recent cohort at a tertiary cancer center: incidence and factors associated with major complications and unexpected hospitalization events.
Jo MG; Lee MW; Ahn S; Kang TW; Song KD; Cha DI; Min JH; Rhim H
Ultrasonography; 2023 Jan; 42(1):41-53. PubMed ID: 36353791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
